Rapid Onset of Antidepressant Action: A New Paradigm in the Research and Treatment of Major Depressive Disorder
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 150 of the 150 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Current therapeutics of depression are similar in their time to antidepressant action and often take weeks to months to achieve response and remission, which commonly results in considerable morbidity and disruption in personal, professional, family, and social life, as well as risk for suicidal behavior. Thus, treatment strategies presenting a rapid improvement of depressive symptoms--within hours or even a few days--and whose effects are sustained would have an enormous impact on public health. This article reviews the published data related to different aspects of rapid improvement of depressive symptoms. DATA SOURCES: Literature for this review was obtained through a search of the MEDLINE database (1966-2007) using the following keywords and phrases: rapid response, antidepressant, time to, glutamate, sleep, therapeutics, latency, and depression. The data obtained were organized according to the following topics: clinical relevance and time course of antidepressant action, interventions showing evidence of rapid response and its potential neurobiological basis, and new technologies for better understanding rapid anti-depressant actions. DATA SYNTHESIS: A limited number of prospective studies evaluating rapid antidepressant actions have been conducted. Currently, only a few interventions have been shown to produce antidepressant response in hours or a few days. The neurobiological basis of these rapid antidepressant actions is only now being deciphered. CONCLUSIONS: Certain experimental treatments can produce antidepressant response in a much shorter period of time than existing medications. Understanding the molecular basis of these experimental interventions is likely to lead to the development of improved therapeutics rather than simply furthering our knowledge of current standard antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, the definition as well the optimal method and time-frame to evaluate rapid antidepressant actions have varied across the literature, without clear consensus (1).”
From Total Sleep Deprivation Followed by Bright Light Therapy as Rapid Relief for Depression: A Pragmatic Randomized Controlled Trial (2021) · cites this paper as [1]
Citations
Cites
Bliss, T. V. P., & Gardner‐Medwin, A. R. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010274 · Cited by 7,437
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationThe functioning and well-being of depressed patients. Results from the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.262.7.914 · Cited by 2,808
Sleep function and synaptic homeostasis
Tononi, G., & Cirelli, C. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.05.002 · Cited by 2,151
The Functioning and Well-being of Depressed Patients: Results From the Medical Outcomes Study
Wells, K. B. (1989) · JAMA · doi:10.1001/jama.1989.03430070062031 · Cited by 2,130
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Gueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Self-citationCingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationKessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868
Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder
Greenberg, B. D., Malone, D. A., Friehs, G. M., Rezai, A. R., Kubu, C. S., Malloy, P. F., Salloway, S. P., Okun, M. S., Goodman, W. K., & Rasmussen, S. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301165 · Cited by 829
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 688
Treatment non‐adherence in affective disorders
Lingam, R., & Scott, J. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.1r084.x · Cited by 635
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.1.14 · Cited by 618
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Phase Advance of the Circadian Sleep-Wake Cycle as an Antidepressant
Wehr, T. A., Wirz-Justice, A., Goodwin, F. K., Duncan, W., & Gillin, J. C. (1979) · Science · doi:10.1126/science.227056 · Cited by 528
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513
Initiation and adaptation: a paradigm for understanding psychotropic drug action
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.151 · Cited by 490
McMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G. J., Laje, G., Fava, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 474
Self-citationHusain, M. M., Rush, A. J., Fink, M., Knapp, R., Petrides, G., Rummans, T., Biggs, M. M., O'Connor, K., Rasmussen, K., Litle, M., et al. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0406 · Cited by 456
Sleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429
Suicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406
Rush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S., Mundt, J. C., Shores-Wilson, K., Biggs, M. M., Woo, A., Nierenberg, A. A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.022 · Cited by 385
The Role of Glutamatergic Neurotransmission in the Pathophysiology of Alcoholism
Tsai, G., & Coyle, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.173 · Cited by 380
Cirelli, C., & Tononi, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09187.2000 · Cited by 369
Cirelli, C., & Tononi, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)03008-0 · Cited by 364
Synaptic plasticity and mood disorders
Duman, R. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001016 · Cited by 363
A direct demonstration of cortical LTP in humans: A combined TMS/EEG study
Esser, S. K., Huber, R., Massimini, M., Peterson, M. J., Ferrarelli, F., & Tononi, G. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.11.003 · Cited by 361
Chen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354
Papakostas, G. I., Nutt, D. J., Hallett, L. A., Tucker, V. L., Krishen, A., & Fava, M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.015 · Cited by 334
Kimbrell, T. A., Little, J. T., Dunn, R. T., Frye, M. A., Greenberg, B. D., Wassermann, E. M., Repella, J. D., Danielson, A. L., Willis, M. W., Benson, B. E., et al. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00195-x · Cited by 333
Wu, J., Buchsbaum, M. S., Gillin, J. C., Tang, C., Cadwell, S., Wiegand, M., Najafi, A., Klein, E., Hazen, K., & Bunney, W. E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1149 · Cited by 326
Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression
van Rossum, E. F. C., Binder, E. B., Majer, M., Koper, J. W., Ising, M., Modell, S., Salyakina, D., Lamberts, S. W. J., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.007 · Cited by 324
Loo, C. K., & Mitchell, P. B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.001 · Cited by 292
Effect of sleep deprivation on brain metabolism of depressed patients
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.538 · Cited by 290
Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020354 · Cited by 285
Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications
Post, R. M. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.09.009 · Cited by 285
Murphy, G. M., Hollander, S. B., Rodrigues, H. E., Kremer, C., & Schatzberg, A. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1163 · Cited by 275
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274
Self-citationA meta-analysis of electroconvulsive therapy efficacy in depression
Kho, K. H., van Vreeswijk, M. F., Simpson, S., & Zwinderman, A. H. (2003) · The Journal of ECT · doi:10.1097/00124509-200309000-00005 · Cited by 265
Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252
Is there a delay in the antidepressant effect? A meta-analysis
Posternak, M. A., & Zimmerman, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0201 · Cited by 250
Parsey, R. V., Olvet, D. M., Oquendo, M. A., Huang, Y.-Y., Ogden, R. T., & Mann, J. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300992 · Cited by 227
Identification of True Drug Response to Antidepressants: Use of Pattern Analysis
Quitkin, F. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190056007 · Cited by 221
Post, A., & Keck, M. E. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00023-1 · Cited by 209
Signaling: cellular insights into the pathophysiology of bipolar disorder
Manji, H. K., & Lenox, R. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00929-x · Cited by 207
Self-citationSleep deprivation reduces proliferation of cells in the dentate gyrus of the hippocampus in rats
Guzmán‐Marín, R., Suntsova, N., Stewart, D. R., Gong, H., Szymusiak, R., & McGinty, D. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.041665 · Cited by 197
Ebert, D., Feistel, H., & Barocka, A. (1991) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(91)90016-j · Cited by 191
Use of Pattern Analysis to Identify True Drug Response: A Replication
Quitkin, F. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150071009 · Cited by 191
Time course of improvement under antidepressant treatment: A survival-analytical approach
Stassen, H. H., Delini-Stula, A., & Angst, J. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90264-m · Cited by 191
Minov, C., Baghai, T. C., Schüle, C., Zwanzger, P., Schwarz, M. J., Zill, P., Rupprecht, R., & Bondy, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01704-9 · Cited by 189
McDermott, C. M., Hardy, M. N., Bazan, N. G., & Magee, J. C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.093781 · Cited by 178
Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets
Carlson, P. J., Singh, J. B., Zarate, C. A., Drevets, W. C., & Manji, H. K. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.009 · Cited by 177
Self-citationArias, B., Catalán, R., Gastó, C., Gutiérrez, B., & Fañanás, L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095350.32154.73 · Cited by 174
Szegedi, A., Müller, M. J., Anghelescu, I., Klawe, C., Kohnen, R., & Benkert, O. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0410 · Cited by 174
Antidepressant Drugs and the Emergence of Suicidal Tendencies
Teicher, M. H., Glod, C. A., & Cole, J. O. (1993) · Drug Safety · doi:10.2165/00002018-199308030-00002 · Cited by 169
Licinio, J., O'Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Lake, S., Tantisira, K. G., Weiss, S. T., & Wong, M.-L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168
Suicide Attempts Among Patients Starting Depression Treatment With Medications or Psychotherapy
Simon, G. E., & Savarino, J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1029 · Cited by 168
The timing, specificity and clinical prediction of tricyclic drug effects in depression
Katz, M. M., Koslow, S. H., Maas, J. W., Frazer, A., Bowden, C. L., Casper, R., Croughan, J., Kocsis, J., & Redmond, E. (1987) · Psychological Medicine · doi:10.1017/s0033291700024831 · Cited by 167
ZARATE, C. A., DU, J., QUIROZ, J., GRAY, N. A., DENICOFF, K. D., SINGH, J., CHARNEY, D. S., & MANJI, H. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.017 · Cited by 164
Self-citationDurham, L. K., Webb, S., Milos, P. M., Clary, C., & Seymour, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1562-3 · Cited by 157
Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152
Stassen, H. H., Angst, J., Hell, D., Scharfetter, C., & Szegedi, A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0805 · Cited by 144
Ballesteros, J., & Callado, L. F. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00404-4 · Cited by 138
Bliss, T. V. P., & Lømo, T. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010273 · Cited by 135
Electroconvulsive therapy vs. paroxetine in treatment‐resistant depression — a randomized study
Folkerts, H. W., Michael, N., Tölle, R., Schonauer, K., Mücke, S., & Schulze‐Mönking, H. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09926.x · Cited by 130
Gangadhar, B. N., Kapur, R. L., & Kalyanasundaram, S. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.141.4.367 · Cited by 121
The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases
Zarate, C. A., & Manji, H. K. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.011 · Cited by 117
Self-citationSmeraldi, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00129-8 · Cited by 116
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.870 · Cited by 114
New approaches to the treatment of refractory depression.
Fava, M. (2000) · PubMed · Cited by 114
Effects of Intrathecal Thyrotropin-Releasing Hormone (Protirelin) in Refractory Depressed Patients
Marangell, L. B. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830150034007 · Cited by 112
Silvestre, J. S., Nadal, R. A., S, M. A. P., & Ferr�, N. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:1<1::aid-da1>3.0.co;2-k · Cited by 111
Silvestre, J. S., Nadal, R., Pallar�s, M., & Ferr�, N. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:1<29::aid-da5>3.0.co;2-0 · Cited by 110
Barriers to seeking treatment for major depression
Blumenthal*, R., & Endicott, J. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:6<273::aid-da3>3.0.co;2-d · Cited by 106
Pindolol Augmentation of Antidepressant Response
Artigas, F., Adell, A., & Celada, P. (2006) · Current Drug Targets · doi:10.2174/138945006775515446 · Cited by 106
Denicoff, K. D., Smith-Jackson, E. E., Disney, E. R., Suddath, R. L., Leverich, G. S., & Post, R. M. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00027-1 · Cited by 104
Gillin, J. C., Buchsbaum, M., Wu, J., Clark, C., & Bunney, W. (2001) · Depression and Anxiety · doi:10.1002/da.1045 · Cited by 103
Pharmacogenomics and antidepressant drugs
Binder, E. B., & Holsboer, F. (2006) · Annals of Medicine · doi:10.1080/07853890600551045 · Cited by 100
Winkler, D., Pjrek, E., Praschak-Rieder, N., Willeit, M., Pezawas, L., Konstantinidis, A., Stastny, J., & Kasper, S. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.031 · Cited by 99
Renaud, L. P., Blume, H. W., Pittman, Q. J., Lamour, Y. A., & Tan, A. T. (1979) · Science · doi:10.1126/science.224461 · Cited by 96
Ongoing Lithium Treatment Prevents Relapse After Total Sleep Deprivation
Benedetti, F., Colombo, C., Barbini, B., Campori, E., & Smeraldi, E. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00007 · Cited by 95
Baune, B. T., Adrian, I., & Jacobi, F. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.09.014 · Cited by 94
Gardner, J., Fornal, C. A., & Jacobs, B. L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00025-0 · Cited by 90
Prolongation of the antidepressant response to partial sleep deprivation by lithium
Baxter, L. R., Liston, E. H., Schwartz, J. M., Altshuler, L. L., WILKINS, J. N., Richeimer, S. H., & Guzé, B. H. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90088-0 · Cited by 87
‘One night’ sleep deprivation stimulates hippocampal neurogenesis
Grassi Zucconi, G., Cipriani, S., Balgkouranidou, I., & Scattoni, R. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.01.009 · Cited by 86
Segman, R. H., Gorfine, M., Lerer, B., & Shapira, B. (1995) · Psychopharmacology · doi:10.1007/bf02245860 · Cited by 81
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier, P. (2001) · PubMed · Cited by 80
Addition of the α2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response
Sanacora, G., Berman, R., Cappiello, A., Oren, D. A., Kugaya, A., Liu, N., Gueorguieva, R. V., Fasula, D., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300418 · Cited by 79
Deliberate self-harm and antidepressant drugs: Investigation of a possible link
Donovan, S., Clayton, A., Beeharry, M., Jones, S., Kirk, C., Waters, K., Gardner, D., Faulding, J., & Madeley, R. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.551 · Cited by 78
Major depressive disorder: remission of associated symptoms.
Trivedi, M. H. (2006) · PubMed · Cited by 73
Szuba, M. P., Baxter, L. R., Altshuler, L. L., Allen, E. M., Guze, B. H., Schwartz, J. M., & Liston, E. H. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90015-9 · Cited by 69
Time course of depression-symptom improvement during treatment with duloxetine
Hirschfeld, R. M. A., Mallinckrodt, C. H., Lee, T. C., & Detke, M. J. (2005) · Depression and Anxiety · doi:10.1002/da.20071 · Cited by 68
Katz, M. M., Koslow, S. H., & Frazer, A. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:6<257::aid-da1>3.0.co;2-9 · Cited by 67
Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression.
Prange, A., Wilson, I. C., Knox, A. E., McClane, T. K., Breese, G., Martin, B., Alltop, L., & Lipton, M. A. (1972) · Journal of Psychiatric Research · doi:10.1016/0022-3956(72)90020-9 · Cited by 65
Clark, C. P., Brown, G. G., Archibald, S. L., Fennema‐Notestine, C., Braun, D. R., Thomas, L. S., Sutherland, A. N., & Gillin, J. C. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.09.007 · Cited by 65
Ph.D, M. M. K., Bowden, C. L., Peter Stokes, M. D., Casper, R. C., Frazer, A., Ph.D, S. H. K., James Kocsis, M. D., Steven Secunda, M. D., Alan Swann, M. D., & Ph.D, N. B. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00038-9 · Cited by 64
Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action
Du, J., Machado-Vieira, R., Maeng, S., Martinowich, K., Manji, H. K., & Zarate, C. A. (2006) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.012 · Cited by 64
Self-citationTollefson, G. D., & Holman, S. L. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00003 · Cited by 63
Glutamate and its role in psychiatric illness
Belsham, B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.279 · Cited by 61
Clark, C. P., Brown, G. G., Frank, L. R., Thomas, L. S., Sutherland, A. N., & Gillin, J. C. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.12.008 · Cited by 59
A Long-term Study to Maximise Migraine Relief with Zolmitriptan
Tepper, S. J., Donnan, G. A., Dowson, A. J., Bomhof, M. A. M., Elkind, A., Meloche, J., Fletcher, P. E., & Millson, D. S. (1999) · Current Medical Research and Opinion · doi:10.1185/03007999909116496 · Cited by 57
Iosifescu, D. V., Nierenberg, A. A., Alpert, J. E., Papakostas, G. I., Perlis, R. H., Sonawalla, S. B., & D, M. F. M. (2004) · Psychosomatics · doi:10.1176/appi.psy.45.5.419 · Cited by 54
Methodology to measure onset of action.
Thase, M. E. (2001) · PubMed · Cited by 50
Payne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46
Self-citationMontgomery, S. A., Bech, P., Blier, P., Möller, H.-J., Nierenberg, A. A., Pinder, R. M., Quitkin, F. M., Reimitz, P.-E., Rosenbaum, J. F., Rush, A. J., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0806 · Cited by 44
Ketamine blocks a conditioned taste aversion (CTA) in neonatal rats1
Mickley, G. A., Schaldach, M. A., Snyder, K. J., Balogh, S. A., Len, T., Neimanis, K., Goulis, P., Hug, J., Sauchak, K., Remmers-Roeber, D. R., et al. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00097-3 · Cited by 44
Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner, J. P., & Boyer, W. F. (1992) · PubMed · Cited by 44
Protirelin (TRH) in Depression
Hollister, L. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760160024006 · Cited by 42
Current concepts of the classification of affective disorders
Angst, J., & Ernst, C. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00001 · Cited by 38
A Study Into Predictors for the Speed of Response to Electroconvulsive Therapy
Kho, K. H., Blansjaar, B. A., Vothknecht, S., Cornelissen, N. M. P., Koomen, E., Zwinderman, A. H., & Linszen, D. H. (2004) · The Journal of ECT · doi:10.1097/00124509-200409000-00006 · Cited by 37
Szuba, M. P., Amsterdam, J. D., Fernando, A. T., Gary, K. A., Whybrow, P. C., & Winokur, A. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169037.17884.79 · Cited by 33
Prediction of efficacy of antidepressant by 1-week test therapy in depression
Nagayama, H., Nagano, K., Ikezaki, A., & Tetsuo, T. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90102-x · Cited by 33
Coryell, W., Coppen, A., Zeigler, V. E., & Biggs, J. T. (1982) · Psychological Medicine · doi:10.1017/s0033291700043385 · Cited by 33
Crespi, F., Keane, P. E., & Morre, M. (1986) · Experimental Brain Research · doi:10.1007/bf00238852 · Cited by 32
Guerra‐Crespo, M., Ubieta, R., Joseph‐Bravo, P., Charli, J., & Pérez‐Martínez, L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01657.x · Cited by 30
Alternative approaches to refractory depression in bipolar illness
Post, R. M., Leverich, G. S., Denicoff, K. D., Frye, M. A., Kimbrell, T. A., & Dunn, R. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:4<175::aid-da4>3.0.co;2-c · Cited by 28
How Long does it Take for Antidepressant Therapies to Act?
Parker, G., Roy, K., Menkes, D. B., Snowdon, J., Boyce, P., Grounds, D., Hughson, B., & Stringer, C. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00684.x · Cited by 26
KRAEMER, H. C., & Pruyn, J. P. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240083013 · Cited by 26
Are 2-week trials sufficient to indicate efficacy?
Montgomery, S. (1995) · PubMed · Cited by 25
A monoamine oxidase B gene variant and short-term antidepressant treatment response
Tadić, A., Rujescu, D., Müller, M. J., Kohnen, R., Stassen, H. H., Dahmen, N., & Szegedi, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.015 · Cited by 24
An ideal trial to test differential onset of antidepressant effect.
Leon, A. C., Blier, P., Culpepper, L., Gorman, J. M., Hirschfeld, R. M. A., Nierenberg, A. A., Roose, S. P., Rosenbaum, J. F., Stahl, S. M., & Trivedi, M. H. (2001) · PubMed · Cited by 21
Papakostas, G. I., Petersen, T., Mischoulon, D., Hughes, M. E., Spector, A. R., Alpert, J. E., Fava, M., & Nierenberg, A. A. (2003) · Comprehensive Psychiatry · doi:10.1053/comp.2003.50012 · Cited by 20
Defining Response in Migraine: Which Endpoints Are Important?
Edmeads, J. G. (2005) · European Neurology · doi:10.1159/000085038 · Cited by 20
Recovery from depression after one ECT
Rich, C. L. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.8.1010b · Cited by 20
Searching for Rational Anti–N-methyl-D-aspartate Treatment for Depression
Tsai, G. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1099 · Cited by 19
Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments
Blier, P. U., & Bergeron, R. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00004 · Cited by 19
Sattin, A. (1998) · Thyroid · doi:10.1089/thy.1998.8.957 · Cited by 18
Bunevičius, R., & Matulevičius, V. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90019-h · Cited by 18
Estienne, M. J., Harter-Dennis, M. J., & Barb, C. R. (2020) · Bioscientifica Proceedings · doi:10.1530/biosciprocs.15.001 · Cited by 17
Age-of-onset or age-cohort changes in the lifetime occurrence of depression?
Stassen, H. H., Ragaz, M., & Reich, T. (1997) · Psychiatric Genetics · doi:10.1097/00041444-199700710-00004 · Cited by 10
Thyrotropin-releasing hormone phase shifts circadian rhythms in hamsters
Gary, K. A., Sollars, P. J., Lexow, N., Winokur, A., & Pickard, G. E. (1996) · Neuroreport · doi:10.1097/00001756-199607080-00021 · Cited by 10
Searching for Rational Anti–N-methyl-D-aspartate Treatment forDepression—Reply
Zarate, C. A., Charney, D. S., & Manji, H. K. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1100 · Cited by 6
Self-citationWinkler, D., Pjrek, E., Pezawas, L., Presslich, O., Tauscher, J. T., & Kasper, S. F. (2003) · Neuropsychobiology · doi:10.1159/000074634 · Cited by 4
The role of primary care in the treatment of depression.
Hirschfeld, R. M. A. (2000) · PubMed · Cited by 1
Cited by
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Self-citationZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811
“Such limitations signifcantly contribute to the life disruptions experienced by individuals ith this disorder, and the delay in treating suicidal behavior is an ssue of particular concern in this already vulnerable population (5).”
BackgroundSelf-citationThe Forced Swim Test as a Model of Depressive-like Behavior
Yankelevitch-Yahav, R., Franko, M., Huly, A., & Doron, R. (2015) · Journal of Visualized Experiments · doi:10.3791/52587 · Cited by 754
Singh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525
“While a number of therapies are available for treatment of major depression, a major limitation of all existing antidepressants is delayed onset of action (1).”
BackgroundSelf-citationBiological, Psychological, and Social Determinants of Depression: A Review of Recent Literature
Remes, O., Mendes, J. F., & Templeton, P. (2021) · Brain Sciences · doi:10.3390/brainsci11121633 · Cited by 482
Metadata
- Authors
- Machado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-06-15
- Volume
- 69
- Issue
- 6
- Pages
- 946-958
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC2699451
- OpenAlex
- W2000031234
- Cited by
- 195
- References
- 147
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 9 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 13 · 2012: 18
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health (Z01MH002853, Z01MH002828, Z01MH002857)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- depression, glutamate, sleep, rapid-acting antidepressants, suicidal behavior, treatment latency
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Severity of Illness Index, Time Factors, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.